Craig Saxton, M.D. Joins Tularik's Board of Directors.Business Editors & Health/Medical Writers BIOWIRE2K SOUTH SAN FRANCISCO South San Francisco, city (1990 pop. 54,312), San Mateo co., W Calif.; inc. 1908. South San Francisco has several industrial parks; its manufactures include medical supplies and equipment, foods, paint, paper products, consumer goods, and clothing. , Calif.--(BW HealthWire)--Sept. 19, 2001 Tularik Inc. (Nasdaq:TLRK) today announced that Craig Saxton, M.D. has been appointed to the company's Board of Directors. From 1993 until his retirement this past March, Dr. Saxton was vice president of Pfizer Inc and executive vice president, Pfizer Global Research and Development at Pfizer's Research and Development headquarters in Groton, Conn. He has held a variety of executive and research posts at Pfizer over a 25-year span. "Craig's addition to our Board comes at an opportune op·por·tune adj. 1. Suited or right for a particular purpose: an opportune place to make camp. 2. Occurring at a fitting or advantageous time: an opportune arrival. time as Tularik's leading drug candidates move toward commercialization," said David V. Goeddel, Ph.D., Tularik's CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "In his most recent position, Craig had worldwide responsibility for the development of all new drugs discovered or licensed by Pfizer for human therapeutic use. During his tenure he played a central role in building Pfizer's formidable pipeline of blockbuster products." Dr. Saxton joined the Central Research Division of Pfizer at their European Research and Development headquarters in Sandwich, U.K. as a medical advisor in 1976. After several positions of increasing responsibility within the Clinical Research Division at Sandwich, he relocated to New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of , where he was appointed senior associate medical director of International Pharmaceuticals in 1981. He was named vice president, medical director of the International Division in 1982. In 1988, Dr. Saxton moved to the Central Research Division in Groton, where he was appointed senior vice president of Clinical Research and Development. The author of many published papers, his research focus has been the metabolic consequences of cardiac disease. A native of Yorkshire, England, Dr. Saxton earned his B.S. in Anatomy in 1962 and his M.D. in 1965 from Leeds University in the U.K. After internship internship /in·tern·ship/ (in´tern-ship) the position or term of service of an intern in a hospital. internship, n the course work or practicum conducted in a professional dental clinic. and residency in Medicine, he was a research fellow in Cardiovascular Research at the University of Leeds Organisation Faculties The various schools, institutes and centres of the University are arranged into nine faculties, each with a dean, pro-deans and central functions:
Dr. Saxton is on the Board of Directors of the African Medical and Research Foundation in New York, and a member of the American Academy The American Academy in Berlin is a non-partisan academic institution in Berlin. It was founded in September 1994 by a group of prominent Americans and Germans, among them Richard Holbrooke, Henry Kissinger, Richard von Weizsäcker, Fritz Stern and Otto Graf Lambsdorff and opened in of Pharmaceutical Physicians and the Connecticut Academy of Science and Engineering. Tularik is engaged in the discovery and development of a broad range of novel and superior orally available drugs that act through the regulation of gene expression Gene modulation redirects here. For information on therapeutic regulation of gene expression, see therapeutic gene modulation.
. . Tularik programs address cancer, viral diseases viral diseases Diseases caused by viruses. Long-term immunity usually follows viral childhood diseases (see chickenpox). The common cold recurs into adulthood because many different viruses cause its symptoms, and immunity against one does not protect against others. , inflammation, immune disorders, lipid disorders, diabetes and obesity. Tularik has established strategic partnerships with Japan Tobacco Inc., Roche Bioscience and Knoll AG. For more information, visit Tularik's Internet website at www.tularik.com. This press release contains "forward-looking" statements. For this purpose, any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "will," "intends" and similar expressions are intended to identify forward-looking statements. There are a number of important factors that could cause the results of Tularik to differ materially from those indicated by these forward-looking statements, including, among others, risks detailed from time to time in Tularik's SEC reports, including the report on Form 10-Q Form 10-Q See 10-Q. for the quarter ended June 30, 2001. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion